Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
NCT00049075
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
128
Enrollment
NETWORK
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
fludarabine phosphate
Sponsor
NCIC Clinical Trials Group